Since 1985, Nelson Laboratories has partnered with the best companies in the world to improve the quality of life by bringing life-enhancing products to market.
The advancements in medical technology over the last 30 years are breathtaking. From the introduction of the first Jarvik artificial heart in December 1982, to the first coronary stents approved in 1994, to rapid innovations in the use of human cells and gene therapies that allow scientists to grow organs in Petri dishes today. These technologies have revolutionized how the medical industry treats complex diseases and disorders to alleviate patient pain and suffering. Improving the quality of life has been an obvious outcome of these marvelous products.
Nelson Laboratories shares a proud history with those in the medical device, pharmaceutical, and tissue industries as they have tested many of the innovative medical products on the market today to ensure they perform safely and effectively. And according to Nelson Laboratories President and CEO, Jeffery Nelson, continuous advancements will be a landmark of the next 30 years at Nelson Labs,
"If a glimpse of the past 30 years is any prediction of the future – we are optimistic. At Nelson Laboratories we are developing new test methods to ensure product safety and efficacy because we understand that Every Test Matters. We are collaborating with clients to overcome their unique product and regulatory hurdles. We are investing in new services, equipment, and facilities; expanding our footprint to localize our services, and developing our talent pool to continue providing the industry’s best expertise and service.
" As a show of appreciation for ongoing partnership with MedTech innovators, Nelson Laboratories will host an Anaheim reception Wednesday February 11, 2015 from 4:00 – 7:00 pm at the DoubleTree Guest Suites Anaheim, 2085 S.
